Royal Bank of Canada’s Molecular Partners MOLN Stock Holding History
Bought
Maintained
Sold
Other funds holding MOLN
BI
SCM
OMC
TCM
Royal Bank of Canada's MOLN Position: Q2 2024 in Review
Royal Bank of Canada sold out of Molecular Partners (MOLN) in Q2 2024, closing a stake of 1,500 shares — an estimated $6K sold.
Royal Bank of Canada first reported a position in MOLN in Q1 2022 and held it in 5 quarters. The position peaked at $6K in Q1 2024. 8 funds tracked by Wall St. Rank hold MOLN as of Q2 2024.
- Royal Bank of Canada reported no remaining Molecular Partners position as of Q2 2024 after selling out during the quarter.
- Royal Bank of Canada sold 1,500 Molecular Partners shares in Q2 2024, an estimated $6K.
- Royal Bank of Canada first reported a position in Molecular Partners in Q1 2022 and held it in 5 quarters.
- Royal Bank of Canada's Molecular Partners position peaked at $6K in Q1 2024.
- 8 funds tracked by Wall St. Rank held Molecular Partners as of Q2 2024.
Based on Royal Bank of Canada's 13F filing for Q2 2024, filed 14 Aug 2024.